ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Studies Show Insurance Barriers and Costs Influence Screening, Treatment and Access in Urology

LAS VEGAS, April 28, 2025 (GLOBE NEWSWIRE) -- New research presented at the American Urological Association (AUA) Annual Meeting in Las Vegas sheds light on the significant impact of insurance barriers and healthcare costs on urologic care across the United States.

Highlights include findings that high-deductible health plans are linked to decreased prostate cancer screening, while medications for urolithiasis could yield substantial savings if purchased through alternative channels like the Mark Cuban Cost Plus Drug Company. Additional studies reveal that states with restrictive vasectomy insurance coverage often have stricter abortion laws, and that prior authorization requirements place a considerable burden on urology practices, potentially affecting patient outcomes. Together, these studies underscore the critical role of insurance policies and affordability in shaping access to essential urologic services.

Researchers will present their study findings covering important updates on insurance barriers from April 26 to 29. Charles Welliver, MD, a men’s health specialist at Albany Medical Health System, posed in-depth questions to the abstract authors, providing key insights into their research. 

“This series of abstracts examines the external barriers that patients and providers must navigate for patients to receive the care they want,” Dr. Welliver said. “How patients and providers interact with insurance frequently affects the quality of care received. Insurers can build barriers to care through a variety of hurdles, like high-deductible insurance plans and prior authorizations. I am also excited to see a study looking at the cost savings of Mark Cuban’s Cost Plus drugs, as I have found this pharmacy to be an incredible benefit to patients.”

The following abstracts are spotlighted in the AUA Press Program:

A recording of the key findings from the abstract authors is available to all press registrants. Fill out the registration form on the website to be added to the virtual programming: https://www.auanet.org/AUA2025/register/press-registration

NOTE TO REPORTERS: Presenting authors and moderators are available to discuss their findings. To arrange an interview with an expert, please contact the AUA Communications Team at Communications@AUAnet.org.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 26,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.


Corey Del Bianco
American Urological Association
443-689-4033
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.69
+3.55 (1.63%)
AAPL  271.49
+5.24 (1.97%)
AMD  203.78
-2.24 (-1.09%)
BAC  51.56
+0.56 (1.10%)
GOOG  299.65
+9.67 (3.33%)
META  594.25
+5.10 (0.87%)
MSFT  472.12
-6.31 (-1.32%)
NVDA  178.88
-1.76 (-0.97%)
ORCL  198.76
-11.93 (-5.66%)
TSLA  391.09
-4.14 (-1.05%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.